Efficacy and Safety of Pembrolizumab in Non-Small Cell Lung Cancer in Our Institution: A Retrospective Study

被引：0
|
作者：
Saijo, N. [1 ]
Inagaki, Y. [1 ]
Abe, Y. [1 ]
Kono, S. [1 ]
Taniguchi, Y. [1 ]
Otsuka, K. [1 ]
Naoki, Y. [1 ]
Tamiya, A. [1 ]
Okishio, K. [1 ]
Atagi, S. [2 ]
机构：
[1] Natl Hosp Org Kinki Chuo Chest Med Ctr, Internal Med, Sakai, Osaka, Japan
[2] Kinki Chuo Chest Med Ctr, Med Oncol, Sakai, Osaka, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Pembrolizumab institution retrospective;
D O I：
10.1016/j.jtho.2018.08.1647
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-87
引用
收藏
页码：S900 / S900
页数：1
相关论文
共 50 条
  • [1] The safety and efficacy of pembrolizumab for the treatment of non-small cell lung cancer
    Mazarico Gallego, Jose Ma
    Herrera Juarez, Mercedes
    Paz-Ares, Luis
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (03) : 233 - 242
  • [2] Real-world efficacy and safety of pembrolizumab in patients with non-small cell lung cancer: a retrospective observational study
    Cavaille, Francois
    Peretti, Mathieu
    Garcia, Marie Eve
    Giorgi, Roch
    Ausias, Nathalie
    Vanelle, Patrice
    Barlesi, Fabrice
    Montana, Marc
    TUMORI JOURNAL, 2021, 107 (01): : 32 - 38
  • [3] Pembrolizumab in non-small cell lung cancer: our experience
    Rizvi, S. A.
    Reza, S.
    Kabba, T.
    Ajzensztejn, D.
    Dwyer, M.
    Randhawa, R.
    Karina, M.
    LUNG CANCER, 2019, 127 : S83 - S83
  • [4] Pembrolizumab toxicity in non-small cell lung cancer: a retrospective analysis
    Keast, Mary
    Button, Mick
    Case, Amy
    Iqbal, Sahar
    Namelo, Clara
    Powell, Ceri
    Powell, James
    Shaw, Paul
    Cox, Samantha
    LUNG CANCER, 2022, 165 : S37 - S38
  • [5] The Efficacy and Safety of Nivolumab, Pembrolizumab, and Atezolizumab in Treatment of Advanced Non-small Cell Lung Cancer
    Chen, Rui
    Tao, Yuquan
    Xu, Xin
    Shan, Liang
    Jiang, Hongyuan
    Yin, Qilei
    Pei, Lingyan
    Cai, Feng
    Ma, Lifang
    Yu, Yongchun
    DISCOVERY MEDICINE, 2018, 26 (143) : 155 - 166
  • [6] Examination of Long-Term Administration of Pembrolizumab in Patients with Non-small Cell Lung Cancer at Our Institution
    Nii, K.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S360 - S360
  • [7] Efficacy and safety of nivolumab in patients with non-small cell lung cancer: a retrospective study in clinical practice
    Montana, Marc
    Garcia, Marie-Eve
    Ausias, Nathalie
    Jeanpierre, Marion
    Meiffren, Margaux
    Giorgi, Roch
    Vanelle, Patrice
    Barlesi, Fabrice
    JOURNAL OF CHEMOTHERAPY, 2019, 31 (02) : 90 - 94
  • [8] Efficacy and safety of immunoradiotherapy for advanced non-small cell lung cancer: a retrospective comparative cohort study
    Gao, Titan
    Sun, Xiaorong
    Hou, Yichen
    Zhang, Mingzhu
    Tan, Weiyue
    Zhang, Yi
    Wang, Jie
    Zheng, Zhonghang
    Li, Chaozhuo
    Qi, Haoran
    Hu, Mengyu
    Xin, Ligang
    JOURNAL OF THORACIC DISEASE, 2023, 15 (06) : 3182 - +
  • [9] Safety of pembrolizumab in patients with non-small cell lung cancer: a real-world study
    Thakrar, D. B.
    Essang, B.
    Echlin, A.
    Murdock, C.
    Lind, M. J.
    LUNG CANCER, 2019, 127 : S40 - S41
  • [10] EFFECTIVENESS AND SAFETY OF PEMBROLIZUMAB IN ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
    Murteira, R.
    Ramos, C.
    Cardoso Borges, F.
    Ferreira, M. M.
    Miranda, A.
    da Costa, Alves F.
    VALUE IN HEALTH, 2018, 21 : S15 - S15
12345